Circulation Research. 2005;97:574-582
Published online before print August 11, 2005,
doi: 10.1161/01.RES.0000181159.83588.4b
(Circulation Research. 2005;97:574.)
© 2005 American Heart Association, Inc.
Cell-Signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation via the A1 Adenosine Receptor
Jianzhong Shen,
Stephen P. Halenda,
Michael Sturek,
Peter A. Wilden
From the Department of Medical Pharmacology and Physiology (J.S., S.P.H., M.S., P.A.W.), Department of Internal Medicine (M.S.), Center for Diabetes and Cardiovascular Health (J.S., M.S., P.A.W.), University of Missouri-Columbia, School of Medicine; and Department of Cellular and Integrative Physiology (M.S.); Indiana University School of Medicine, Indianapolis.
Correspondence to Peter A. Wilden, PhD, Dept of Medical Pharmacology and Physiology, MA 415, Medical Sciences Bldg, University of Missouri-Columbia, School of Medicine, Columbia, MO 65212. E-mail WildenP{at}health.missouri.edu
For decades, it has been thought that adenosine is exclusively antimitogenic on vascular smooth muscles via the A2-type adenosine receptor. Recently, we have demonstrated that adenosine stimulates proliferation of porcine coronary artery smooth muscle cells (CASMC) through the A1 adenosine receptor. However, the cell-signaling mechanisms underlying A1 receptormediated CASMC proliferation in response to adenosine have not been defined. Here, we show that in cultured CASMC, adenosine stimulates phosphorylation of extracellular signalregulated kinase (ERK), Jun N-terminal kinase (JNK), and AKT in a concentration- and time-dependent manner. This effect is fully mimicked by NECA (nonselective agonist), largely mimicked by CCPA (A1-selective agonist), weakly mimicked by 2-Cl-IB-MECA (A3-selective agonist), but not by CGS21680 (A2A-selective agonist), indicating that adenosine signals strongly via the A1 receptor to these mitogenic signaling pathways. This interpretation is supported by the finding that adenosine- and CCPA-induced phosphorylation of ERK, JNK, and AKT are inhibited by pertussis toxin (inactivator of Gi proteins) and by DPCPX (A1-selective antagonist), but not by SCH58261, MRS1706, and VUF5574 (A2A-, A2B-, and A3-selective antagonists, respectively). In addition, adenosine- and CCPA-induced phosphorylation of ERK, JNK, and AKT is inhibited, respectively, by U0126, PD98059 (mitogen-activated protein kinase kinase inhibitors), SP600125 (JNK kinase inhibitor), and wortmannin (phosphatidylinositol 3-kinase inhibitor). Furthermore, these kinase inhibitors abolish or diminish adenosine- and CCPA-induced increases in the rate of cellular DNA synthesis, bromodeoxyuridine incorporation, protein synthesis, and cell number. We conclude that adenosine activates the ERK, JNK, and phosphatidylinositol 3-kinase/AKT pathways primarily through the A1 receptor, leading to CASMC mitogenesis.
Key Words: porcine protein kinase phosphorylation extracellular signalregulated kinase Jun N-terminal kinase AKT G protein
This article has been cited by other articles:

|
 |

|
 |
 
H. R. Ansari, B. Teng, A. Nadeem, K. P. Roush, K. H. Martin, J. Schnermann, and S. J. Mustafa
A1 adenosine receptor-mediated PKC and p42/p44 MAPK signaling in mouse coronary artery smooth muscle cells
Am J Physiol Heart Circ Physiol,
September 1, 2009;
297(3):
H1032 - H1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shen and P. E. DiCorleto
ADP Stimulates Human Endothelial Cell Migration via P2Y1 Nucleotide Receptor-Mediated Mitogen-Activated Protein Kinase Pathways
Circ. Res.,
February 29, 2008;
102(4):
448 - 456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shen and P. E. DiCorleto
Adenosine Prompts the Heart to Recruit Endothelial Progenitors
Circ. Res.,
February 15, 2008;
102(3):
280 - 282.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Reichelt, L. Willems, J. N. Peart, K. J. Ashton, G. P. Matherne, M. R. Blackburn, and J. P. Headrick
Heart/Cardiac Muscle: Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine
Exp Physiol,
January 1, 2007;
92(1):
175 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|